Loss of Sirt3 limits bone marrow cell-mediated angiogenesis and cardiac repair in post-myocardial infarction

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Zeng, Heng ^a   Li, Lanfang ^a   Chen, Jian Xiong ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; SIRTUIN 3; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; SIRT3 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; COLONY FORMATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HEART INFARCTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL TRANSPLANTATION; WILD TYPE; ANIMAL; BONE MARROW TRANSPLANTATION; CELL CULTURE; FIBROSIS; GENETICS; HEART; HEART MUSCLE; KNOCKOUT MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; FIBROSIS; HEART; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; SIRTUIN 3;

EID: 84906996464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107011     Document Type: Article

References (57)

1. Tanno M, Kuno A, Horio Y, Miura T (2012) Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol 107: 273. 10.1007/s00395-012-0273-5 [doi].
2. Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP (2010) Mitochondrial SIRT3 and heart disease. Cardiovasc Res 88: 250-256. cvq250 [pii];10.1093/cvr/cvq250 [doi].
3. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282: 6823-6832. M609554200 [pii];10.1074/jbc.M609554200 [doi].
4. Becatti M, Taddei N, Cecchi C, Nassi N, Nassi PA, et al (2012) SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell Mol Life Sci 69: 2245-2260. 10.1007/s00018-012-0925-5 [doi].
5. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA, et al (2011) SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 589: 4545-4554. jphysiol.2011.211219 [pii];10.1113/jphysiol. 2011.211219 [doi].
6. Sundaresan NR, Pillai VB, Gupta MP (2011) Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. J Mol Cell Cardiol 51: 614-618. S0022-2828(11)00029-0 [pii];10.1016/j.yjmcc.2011.01.008 [doi].
7. Zu Y, Liu L, Lee MY, Xu C, Liang Y, et al (2010) SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res 106: 1384-1393. CIRCRESAHA.109.215483 [pii];10.1161/CIRCRESAHA.109.215483 [doi].
8. Vinciguerra M, Santini MP, Martinez C, Pazienza V, Claycomb WC, et al (2012) mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11: 139-149. 10.1111/j.1474-9726.2011.00766.x [doi].
9. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, et al (2008) Endurance exercise as a countermeasure for aging. Diabetes 57: 2933-2942. db08-0349 [pii];10.2337/db08-0349 [doi].
10. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, et al (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85: 258-263. S0888-7543(04)00308-8 [pii];10.1016/j.ygeno.2004.11.003 [doi].
11. Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, et al (2003) Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 38: 1065-1070. S0531556503002092 [pii].
12. Palacios OM, Carmona JJ, Michan S, Chen KY, Manabe Y, et al (2009) Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY) 1: 771-783.
13. Someya S, Yu W, Hallows WC, Xu J, Vann JM, et al (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143: 802-812. S0092-8674(10)01138-4 [pii];10.1016/j.cell.2010.10.002 [doi].
14. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, et al (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285: 3133-3144. M109.077271 [pii];10.1074/jbc.M109.077271 [doi].
15. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, et al (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119: 2758-2771. 39162 [pii];10.1172/JCI39162 [doi].
16. Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103: 1231-1236.
17. Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW (2004) Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 264: 63-74.
18. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, et al (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699.
19. Sack MN (2012) The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging. J Mol Cell Cardiol 52: 520-525. S0022-2828(11)00470-6 [pii];10.1016/j.yjmcc.2011.11.004 [doi].
20. Li L, Zeng H, Hou X, He X, Chen JX (2013) Myocardial Injection of Apelin-Overexpressing Bone Marrow Cells Improves Cardiac Repair via Upregulation of Sirt3 after Myocardial Infarction. PLoS One 8: e71041. 10.1371/journal. pone.0071041 [doi]; PONE-D-13-05351 [pii].
21. Brown K, Xie S, Qiu X, Mohrin M, Shin J, et al (2013) SIRT3 reverses agingassociated degeneration. Cell Rep 3: 319-327. S2211-1247(13)00012-0 [pii];10.1016/j.celrep.2013.01.005 [doi].
22. Li L, Zeng H, Chen JX (2012) Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol 303: H605-H618. ajpheart.00366.2012 [pii];10.1152/ajpheart.00366.2012 [doi].
23. Tuo QH, Zeng H, Stinnett A, Yu H, Aschner JL, et al (2008) Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 294: H2547-H2557.
24. Chen JX, Stinnett A (2008) Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 57: 3335-3343.
25. Zeng H, Li L, Chen JX (2012) Overexpression of Angiopoietin-1 Increases CD133+/c-kit+ Cells and Reduces Myocardial Apoptosis in db/db Mouse Infarcted Hearts. PLoS One 7: e35905. 10.1371/journal.pone.0035905 [doi]; PONE-D-11-21968 [pii].
26. Li L, Crockett E, Wang DH, Galligan JJ, Fink GD, et al (2002) Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol 22: 249-255.
27. Chen JX, Stinnett A (2008) Critical role of the NADPH oxidase subunit p47(phox) on vascular TLR expression and neointimal lesion formation in highfat diet-induced obesity. Lab Invest 88: 1316-28.
28. Chen JX, Tuo Q, Liao DF, Zeng H (2012) Inhibition of protein tyrosine phosphatase improves angiogenesis via enhancing Ang-1/Tie-2 signaling in diabetes. Exp Diabetes Res 2012: 836759. 10.1155/2012/836759 [doi].
29. Chen JX, Zeng H, Tuo QH, Yu H, Meyrick B, et al (2007) NADPH oxidase modulates myocardial Akt, ERK1/2 activation and angiogenesis after hypoxia/reoxygenation. Am J Physiol Heart Circ Physiol 292: H1664-H1674.
30. Chen JX, Zeng H, Lawrence ML, Blackwell TS, Meyrick B (2006) Angiopoietin- 1-induced Angiogenesis is Modulated by Endothelial NADPH Oxidase. Am J Physiol Heart Circ Physiol 291: H1563-72.
31. Assmus B, Iwasaki M, Schachinger V, Roexe T, Koyanagi M, et al (2012) Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur Heart J 33: 1911-1919. ehr388 [pii];10.1093/eurheartj/ehr388 [doi].
32. Giralt A, Villarroya F (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J 444: 1-10. BJ20120030 [pii];10.1042/BJ20120030 [doi].
33. Liu Y, Zhang D, Chen D (2011) SIRT3: Striking at the heart of aging. Aging (Albany NY) 3: 1-2. 100256 [pii].
34. Sack MN (2011) Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart. Am J Physiol Heart Circ Physiol 301: H2191-H2197. ajpheart.00199.2011 [pii];10.1152/ajpheart. 00199.2011 [doi].
35. Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP (2008) SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 28: 6384-6401. MCB.00426-08 [pii];10.1128/MCB.00426-08 [doi].
36. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, et al (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703. S0140-6736(03)14232-8 [pii];10.1016/S0140-6736(03)14232-8 [doi].
37. Hu X, Dai S, Wu WJ, Tan W, Zhu X, et al (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116: 654-663. CIRCULATIONAHA.106.672451 [pii];10.1161/CIRCULATIONAHA. 106.672451 [doi].
38. Frederick JR, Fitzpatrick JR, III, McCormick RC, Harris DA, Kim AY, et al (2010) Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation 122: S107-S117. 122/11-suppl-1/S107 [pii];10.1161/CIRCULATIONAHA.109.930404 [doi].
39. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, et al (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105: 199-206. 10.1182/blood-2004-05-1831 [doi];2004-05-1831 [pii].
40. Wojakowski W, Tendera M (2005) Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 43: 229-232.
41. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, et al (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17: 41-52. S1535-6108(09)00428-0 [pii];10.1016/j.ccr.2009.11.023 [doi].
42. Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S (2002) Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90: E89-E93.
43. Fan M, Chen W, Liu W, Du GQ, Jiang SL, et al (2010) The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res 13: 429-438. 10.1089/rej.2009.0986 [doi].
44. Khan M, Mohsin S, Khan SN, Riazuddin S (2011) Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J Cell Mol Med 15: 1515-1527. JCMM998 [pii];10.1111/j.1582-4934.2009.00998.x [doi].
45. Zhang H, Fazel S, Tian H, Mickle DA, Weisel RD, et al (2005) Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 289: H2089-H2096. 289/5/H2089 [pii];10.1152/ajpheart.00019.2005 [doi].
46. Gottlieb RA, Finley KD, Mentzer RM Jr (2009) Cardioprotection requires taking out the trash. Basic Res Cardiol 104: 169-180. 10.1007/s00395-009-0011-9 [doi].
47. Kim I, Rodriguez-Enriquez S, Lemasters JJ (2007) Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462: 245-253. S0003-9861(07)00162-2 [pii];10.1016/j.abb.2007.03.034 [doi].
48. Hamacher-Brady A, Brady NR, Gottlieb RA (2006) Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 281: 29776-29787. M603783200 [pii];10.1074/jbc.M603783200 [doi].
49. Hamacher-Brady A, Brady NR, Gottlieb RA, Gustafsson AB (2006) Autophagy as a protective response to Bnip3-mediated apoptotic signaling in the heart. Autophagy 2: 307-309. 2947 [pii].
50. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, et al (2007) Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14: 146-157. 4401936 [pii];10.1038/sj.cdd.4401936 [doi].
51. Kanamori H, Takemura G, Goto K, Maruyama R, Ono K, et al (2011) Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am J Physiol Heart Circ Physiol 300: H2261-H2271. ajpheart.01056.2010 [pii];10.1152/ajpheart.01056.2010 [doi].
52. Przyklenk K, Undyala VV, Wider J, Sala-Mercado JA, Gottlieb RA, et al (2011) Acute induction of autophagy as a novel strategy for cardioprotection: getting to the heart of the matter. Autophagy 7: 432-433. 14395 [pii].
53. Wang HJ, Zhang D, Tan YZ, Li T (2013) Autophagy in endothelial progenitor cells is cytoprotective in hypoxic conditions. Am J Physiol Cell Physiol 304: C617-C626. ajpcell.00296.2012 [pii];10.1152/ajpcell.00296.2012 [doi].
54. Chen J, Xavier S, Moskowitz-Kassai E, Chen R, Lu CY, et al (2012) Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol 180: 973-983. S0002-9440(11)01102-3 [pii];10.1016/j.ajpath.2011.11.033 [doi].
55. Lee Y, Jung J, Cho KJ, Lee SK, Park JW, et al (2013) Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem 114: 79-88. 10.1002/jcb.24303 [doi].
56. Phadwal K, Watson AS, Simon AK (2013) Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging. Cell Mol Life Sci 70: 89-103. 10.1007/s00018-012-1032-3 [doi].
57. Zhuang W, Li B, Long L, Chen L, Huang Q, et al (2011) Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 129: 2720-2731. 10.1002/ijc.25975 [doi].